title: Developmental changes of hypothalamic, pituitary and striatal tachykinins in response to testosterone: influence of prenatal melatonin.
abstract: Substance P (SP) and neurokinin A (NKA), members of the family of mammalian tachykinins, are involved in the regulation of many physiological functions and are widely distributed in mammalian tissues. In this report, the effects of prenatal melatonin on the postnatal developmental pattern of NKA, and SP, and on testosterone secretion were investigated. Also, tachykinin response to the administration of testosterone propionate (TP) was studied. The brain areas studied were medio-basal-hypothalamus, pituitary gland and striatum. Male rat offspring of control or melatonin treated mother rats were studied at different ages of the sexual development: infantile, juvenile or prepubertal periods, and pubertal period. Both groups received exogenous TP (control-offspring+TP and MEL-offspring+TP), or the vehicle (control-offspring+placebo and MEL-offspring+placebo). Hypothalamic concentrations of all peptides studied in control-offspring+placebo remained at low levels until the juvenile period, days 30-31 of age. After this age, increasing concentrations of these peptides were found, with peak values at puberty, 40-41 days of age, then declining until adulthood. In the MEL-offspring+placebo a different pattern of development was observed; hypothalamic concentrations of NKA and SP from the infantile period until the end of juvenile period were significantly higher than in control-offspring+placebo. TP administration exerted a more marked influence on MEL-offspring than on control-offspring and prevented the elevation in tachykinin concentrations associated with prenatal melatonin treatment. TP administration to control-offspring resulted in significantly reduced (P < 0.05) tachykinin concentration only at 40-41 days of age, and increased (P < 0.01) during infantile period as compared to control-offspring+placebo. Pituitary NKA concentrations were lower than in the hypothalamus. In control-offspring+placebo pituitary NKA levels did not show significant changes throughout sexual development. A different developmental pattern was observed in MEL-offspring+placebo, with significantly increased (P < 0.05) pituitary NKA concentrations at 35-36 days of age than in control-offspring+placebo. TP administration to control-offspring influenced pituitary NKA levels at the end of the infantile and pubertal periods, showing at both stages significantly higher (P < 0.05) NKA levels as compared to control-offspring+placebo. NKA levels in MEL-offspring+TP were only affected at 21-22 days of age, showing significantly increased (P < 0.01) values as compared to MEL-offspring+placebo. Striatal tachykinin concentrations in control-offspring did not undergo important modifications throughout sexual development, but during the prepubertal period they started to increase. Maternal melatonin and TP injections produced short-lived alterations during the infantile period. The results showed that prenatal melatonin delayed the postnatal testosterone secretion pattern until the end of the pubertal period and postnatal peptide secretion in brain structures. Consequently, all functions depending of the affected areas will in turn, be affected.
authors.affiliation: Dpto. Biología Funcional. Area Fisiología, Fac. Medicina, Univ. Oviedo, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Díaz Rodríguez
authors.forename: B
authors.initials: B
authors.lastname: Díaz López
authors.forename: L
authors.initials: L
authors.lastname: Debeljuk
authors.forename: A I
authors.initials: AI
authors.lastname: Esquifino Parras
authors.forename: A
authors.initials: A
authors.lastname: Arce Fraguas
authors.forename: B
authors.initials: B
authors.lastname: Marín Fernández
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects*; D005260:Female; D007031:Hypothalamus / Q000187:drug effects*; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D015288:Neurokinin A / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017208:Rats, Wistar; D013373:Substance P / Q000378:metabolism; D015320:Tachykinins / Q000378:metabolism*; D013739:Testosterone / Q000097:blood*
chemical_list: D015320:Tachykinins; D013373:Substance P; D013739:Testosterone; D015288:Neurokinin A; D008550:Melatonin